Revenue up 58% in Fourth Quarter, 53% for Year; Member Growth of 55% for YearAchieves Positive Net Income in Fourth Quarter; Significantly ...

Fourth quarter results reflect revenue growth, margin expansion and order momentum. Revenue increased 17% to $143.4 million, including 15% organic growth on a constant currency ba ...

Fourth Quarter Net Income Increased 9% to $7 Million; Adjusted EBITDA Increased 34% to $29 Million Full Year 2025 Revenue ...

PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...

The Law on the Administration of Activities of International Non-Governmental Organizations in the People’s Republic of China (the INGO Law) stipulates that ‘international non-governmental ...

Funding Circle Holdings plc. Full Year 2025 Results. FY 2026 REVENUE GUIDANCE ACHIEVED A YEAR EARLY. UPGRADED FY 2026 ...

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural industries ...

Maple Leaf Foods Inc. ("Maple Leaf Foods" or "the Company") today reported its financial results for the fourth quarter and ...

Surpasses $100 Million in Annual Revenue, First Time in the Company’s History ~~ MAUs of 52 Million in Q4, Representing 11% Quarterly ...

Paramount Skydance plans to redevelop its historic Hollywood studio as it consolidates the vast Warner Bros. and Paramount ...

TSX: MFI Maple Leaf Foods reports fourth quarter Revenue growth of 8.1% and Adjusted EBITDA growth of 8.3% MISSISSAUGA, ON, March 5, 2026 /PRNewswire/ - Maple Leaf ...

Wiley , a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the third quarter ended ...